Search Results

Editor's Note: This editorial was written before the emergence of the omicron variant of COVID-19. Welcome to 2022! By the time you read this, you have probably already put away all those holiday decorations, sworn off overeating, and promised

COVID-19 and Decreases in Cancer Screening As a panel of experts at the NCCN 2021 Virtual Annual Conference explained, hospitals in the Northeast, including Dana-Farber Cancer Institute and Yale Smilow Cancer Hospital, experienced a surge in

As oncologists in the era of coronavirus disease 2019 (COVID-19), we are tasked with caring for patients who are at high risk for adverse effects from the novel coronavirus (SARS-CoV-2). 1 Patients with cancer face fear and anxiety related to their

and complete version of these NCCN Guidelines, go to NCCN.org . Current Topic of Interest: Vaccination Against Respiratory Infection Before the COVID-19 pandemic, the influenza virus was a leading concern due to its role in the development of

INTRODUCTION : Telemedicine retains potential for increasing access to specialty providers in underserved and rural communities. COVID-19 accelerated adoption of tele-healthcare beyond rural populations, serving as a primary modality of patient

Background: Oncology providers caring for ill and dying patients are at high risk for burnout, compassion fatigue, and moral distress. Emphasized by the COVID-19 pandemic, workload stress, frontline fears, fluctuating procedures, isolation

faces, and stay home when they are sick. I would venture to say that we will see fewer deaths next year from influenza likely because the public will practice better hygiene than before. Forgive me for not writing about cancer this month. COVID-19 has

Coronavirus Disease 2019 (COVID-19) Resources for the Cancer Care Community NCCN recognizes the rapidly changing medical information relating to COVID-19 in the oncology ecosystem, but understands that a forum for sharing best practices and specific

The NCCN 2020 Annual Conference—originally scheduled for March 19 through 22—was one of the first major oncology meetings to be impacted by the coronavirus disease 2019 (COVID-19) pandemic. Ordinarily, NCCN would have welcomed some 1

-trillion-dollar post-COVID-19 reality? Accessed August 19, 2020. Available at: https://www.mckinsey.com/∼/media/McKinsey/Industries/Healthcare%20Systems%20and%20Services/Our%20Insights/Telehealth%20A%20quarter%20trillion%20dollar%20post%20COVID%2019%20reality/Telehealth-A-quarter-trilliondollar-post-COVID